Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

Cell & Gene Therapy (2)

AGC Biologics partners with Genenta Science

1 min read

Genenta and AGC Biologics Expand Development & Manufacturing Agreement

February 7, 2023 at 7:57 AM

Read press release

AGC Biologics receiving innovation and leadership award

1 min read

AGC Biologics Receives Excellence in Innovation and Leadership by Le Fonti Business News in Italy

December 1, 2022 at 6:45 AM

Cell & Gene Therapy Press Release Business Updates

Read press release

RoosterBio and AGC Biologics partner up.

2 min read

RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies

August 16, 2022 at 8:00 AM

Cell & Gene Therapy Press Release Business Updates

Read press release

AGC Biologics partnership with Altheia Science.

1 min read

AGC Biologics Supports Altheia Science’s Gene Therapy Programs

July 27, 2022 at 6:00 AM

Cell & Gene Therapy Press Release Business Updates

Read press release

AGC Biologics honored by American Business Awards

1 min read

AGC Biologics Named Manufacturing Company of the Year by American Business Awards

June 29, 2022 at 6:00 AM

Cell & Gene Therapy Mammalian & mAbs Press Release Business Updates Microbial

Read press release

Prev 1 2

Our Company

Locations

Policies

Offerings

Services

Specialized Platforms & Programs

News & Blogs

Resources

Fact Sheet Quick Links

Join Us

What Drives Us

Meet Our Teams

Press Releases

Cell & Gene Therapy (2)

Genenta and AGC Biologics Expand Development & Manufacturing Agreement

AGC Biologics Receives Excellence in Innovation and Leadership by Le Fonti Business News in Italy

RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies

AGC Biologics Supports Altheia Science’s Gene Therapy Programs

AGC Biologics Named Manufacturing Company of the Year by American Business Awards

Our Mission

Links

News

AGC Biologics’ Milan Site to Prepare Lentiviral Vector Commercial Manufacturing for Adaptimmune’s Lete-Cel Product

Events

NextGen Biomed, March 12-14